CSS LLC’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-21,000
| Closed | -$1.11M | – | 932 |
|
|
2022
Q4 | $1.11M | Buy |
21,000
+4,000
| +24% | +$200K | 0.06% | 241 |
|
|
2022
Q3 | $791K | Sell |
17,000
-8,600
| -34% | -$449K | 0.04% | 402 |
|
|
2022
Q2 | $1.46M | Buy |
25,600
+5,000
| +24% | +$283K | 0.06% | 353 |
|
|
2022
Q1 | $1.26M | Sell |
20,600
-29,000
| -58% | -$1.51M | 0.05% | 374 |
|
|
2021
Q4 | $2.6M | Sell |
49,600
-24,900
| -33% | -$1.05M | 0.09% | 200 |
|
|
2021
Q3 | $2.78M | Sell |
74,500
-47,000
| -39% | -$1.63M | 0.12% | 177 |
|
|
2021
Q2 | $4.96M | Buy |
121,500
+79,400
| +189% | +$2.93M | 0.21% | 98 |
|
|
2021
Q1 | $1.43M | Buy |
42,100
+29,100
| +224% | +$1.01M | 0.06% | 298 |
|
|
2020
Q4 | $414K | Buy |
13,000
+12,700
| +4,233% | +$334K | 0.02% | 501 |
|
|
2020
Q3 | $8K | Sell |
300
-29,700
| -99% | -$678K | ﹤0.01% | 779 |
|
|
2020
Q2 | $770K | Buy |
+30,000
| New | +$607K | 0.04% | 314 |
|
|
2020
Q1 | – | Sell |
-65,900
| Closed | -$2.26M | – | 783 |
|
|
2019
Q4 | $2.26M | Buy |
+65,900
| New | +$791K | 0.13% | 144 |
|
Other funds holding ITCI
KIM
HNB